Exit strategies in inflammatory bowel disease: Looking beyond anti-tumor necrosis factors

The long-term management of patients with inflammatory bowel disease (IBD) is still a matter of debate, and no clear guidelines have been issued. In clinical practice, gastroenterologists often have to deal with patients in prolonged remission after immunomodulatory or immunosuppressive therapies. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Crispino, Federica, Michielan, Andrea, Grova, Mauro, Tieppo, Chiara, Mazza, Marta, Rogger, Teresa Marzia, Armelao, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198103/
https://www.ncbi.nlm.nih.gov/pubmed/37214561
http://dx.doi.org/10.12998/wjcc.v11.i12.2657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198103/
https://www.ncbi.nlm.nih.gov/pubmed/37214561
http://dx.doi.org/10.12998/wjcc.v11.i12.2657

Ejemplares similares